International Journal of Pharmaceutical Compounding

A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

LEARN MORE

Atropine Sulfate 0.1 mg/mL in SyrSpend SF pH4 Oral Suspension

Author(s): Allen Loyd V Jr

Issue: Sep/Oct 2021 - Volume 25, Number 5
View All Articles in Issue

Page(s): 412

Atropine Sulfate 0.1 mg/mL in SyrSpend SF pH4 Oral Suspension Page 1

Download in electronic PDF format for $65

Abstract: A formulation for preparing Atropine Sulfate 0.1 mg/mL in SyrSpend SF pH4 Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen, Jr, PhD, RPh, atropine sulfate, formulation, oral suspension, anticholinergic agent, antispasmodic agent, muscle spasms, belladonna alkaloid, d-hyoscyamine, l-hyoscyamine

Related Categories: FORMULATIONS, MUSCULOSKELETAL DISORDERS, NEUROLOGY

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Atropine Sulfate 0.1 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Sep/Oct 2021 Pg. 412
Wetting and/or Solubilizing Agents, Featured Excipient: Allen Loyd V Jr	Jul/Aug 2001 Pg. 310-312
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr	Nov/Dec 2003 Pg. 449-450
Stability of Alprazolam, Atropine Sulfate, Glutamine, Levofloxacin, Metoprolol Tartrate, Nitrofurantoin, Ondansetron Hydrochloride, Oxandrolone, Pregabaline, and Riboflavin in SyrSpend SF pH4 Oral Suspensions de Oliveira Ferreira Anderson, Polonini Hudson C, Loures da Silva Sharlene, Cerqueira de Melo Victor Augusto, de Andrade Laura, Fernandes Brandão Marcos Antônio	May/Jun 2017 Pg. 255-263
Hyoscyamine Sulfate 0.125-mg and Phenobarbital 15-mg/mL Oral Drops Allen Loyd V Jr	May/Jun 2003 Pg. 220
Atropine Sulfate 1% Ophthalmic Solution Allen Loyd V Jr	May/Jun 2015 Pg. 242
Alprazolam 1 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Mar/Apr 2022 Pg. 140
Dapsone 2 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Nov/Dec 2017 Pg. 491
Metoprolol Tartrate 10 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Nov/Dec 2021 Pg. 503
Ondansetron Hydrochloride 0.8 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Jan/Feb 2020 Pg. 60
Basics of Compounding for Cough Allen Loyd V Jr	Nov/Dec 2004 Pg. 462-465
Quinidine Sulfate 10 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Mar/Apr 2020 Pg. 136
Enalapril Maleate 1 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Nov/Dec 2018 Pg. 494
Atropine Overdosage with a Suppository Formulation Containing Atropine Sulfate Allen Loyd V Jr	Jul/Aug 1997 Pg. 271-273
Metronidazole Benzoate 70 mg/mL in SyrSpend SF Oral Suspension Allen Loyd V Jr	Jul/Aug 2018 Pg. 320
Hydroxychloroquine Sulfate 25 mg/mL in Oral Mix or Oral Mix SF Allen Loyd V Jr	Nov/Dec 2017 Pg. 494
Penicillamine-D 50 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Jan/Feb 2018 Pg. 55
Carbamazepine 25-mg/mL in SyrSPend SF pH4 Oral Suspension Allen Loyd V Jr	Sep/Oct 2017 Pg. 409
Ketoconazole 20-mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	May/Jun 2017 Pg. 233